180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.

Munro APS, Drysdale SB, Cathie K, Flamein F, Knuf M, Collins AM, Hill HC, Kaiser F, Cohen R, Pinquier D, Vassilouthis NC, Carreno M, Moreau C, Bourron P, Marcelon L, Mari K, Roberts M, Tissières P, Royal S, Faust SN, HARMONIE Study Group

Open source

DOI: 10.1016/s2352-4642(25)00102-6
Published: 2025 Jun
Container: The Lancet. Child & adolescent health
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-25-00102-6,
  title = {180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.},
  author = {Munro APS and Drysdale SB and Cathie K and Flamein F and Knuf M and Collins AM and Hill HC and Kaiser F and Cohen R and Pinquier D and Vassilouthis NC and Carreno M and Moreau C and Bourron P and Marcelon L and Mari K and Roberts M and Tissières P and Royal S and Faust SN and HARMONIE Study Group},
  year = {2025},
  journal = {The Lancet. Child \& adolescent health},
  doi = {10.1016/s2352-4642(25)00102-6},
  url = {https://doi.org/10.1016/s2352-4642(25)00102-6}
}

RIS

TY  - JOUR
TI  - 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.
AU  - Munro APS
AU  - Drysdale SB
AU  - Cathie K
AU  - Flamein F
AU  - Knuf M
AU  - Collins AM
AU  - Hill HC
AU  - Kaiser F
AU  - Cohen R
AU  - Pinquier D
AU  - Vassilouthis NC
AU  - Carreno M
AU  - Moreau C
AU  - Bourron P
AU  - Marcelon L
AU  - Mari K
AU  - Roberts M
AU  - Tissières P
AU  - Royal S
AU  - Faust SN
AU  - HARMONIE Study Group
PY  - 2025
JO  - The Lancet. Child & adolescent health
DO  - 10.1016/s2352-4642(25)00102-6
UR  - https://doi.org/10.1016/s2352-4642(25)00102-6
ER  -

APA

APS, M., SB, D., K, C., F, F., M, K., AM, C., HC, H., F, K., R, C., D, P., NC, V., M, C., C, M., P, B., L, M., K, M., M, R., P, T., S, R., SN, F., & Group, H. S. (2025). 180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial.. The Lancet. Child & adolescent health. https://doi.org/10.1016/s2352-4642(25)00102-6

Source records

pubmed · retrieved 2026-09-26T09:19:15.065Z